HB2109, titled the “Arizona End Organ Harvesting Act,” adds new insurance coverage limitations related to human organ transplants. The bill allows certain Arizona health coverage arrangements — including hospital service corporations, medical service corporations, health care services organizations, disability insurers, group or blanket disability policies, and the state Medicaid administration — to limit coverage for a transplant or post-transplant care when the transplant is performed in the People’s Republic of China or the Hong Kong Special Administrative Region, or when the organ was procured through a sale or donation originating there.
The bill does not require any insurer or the Medicaid administration to cover organ transplants at all, and it preserves the ability of carriers and the administration to deny coverage for any valid reason. For the Medicaid provision, any coverage limitation is subject to approval by the Centers for Medicare and Medicaid Services. The measure is framed as a prohibition on supporting forced organ harvesting through insurance coverage, but its operative effect is to authorize coverage restrictions tied to the location of the transplant or the origin of the organ.
Impact
HB2109 amends multiple sections of Title 20 and Title 36 of the Arizona Revised Statutes to create parallel insurance rules across several lines of coverage. It affects hospital service corporations, medical service corporations, health care services organizations, disability insurance policies, group or blanket disability policies, and the Arizona Medicaid program, while leaving existing discretion to deny claims for other valid reasons intact. The bill may influence how Arizona insurers and the state health care administration evaluate transplant-related claims involving China or Hong Kong and could require policy and claims-processing changes for affected carriers and administrators.
Sentiment
The bill appears to have generally favorable support in the Legislature, advancing through committee and floor votes with clear majorities in both chambers. It passed the House Health & Human Services Committee 7-5, the House Rules Committee 8-0, the House third reading 38-20, the Senate Health and Human Services Committee 4-3, and the Senate third reading 18-11. The vote pattern suggests the measure was supported by most Republicans and opposed by many Democrats, with the strongest support coming in procedural and final passage votes.
Contention
The main point of contention is whether Arizona should authorize insurers and the Medicaid program to restrict coverage for transplants connected to China or Hong Kong, which supporters frame as a response to forced organ harvesting and opponents may view as discriminatory, overly broad, or difficult to administer. Another likely issue is the bill’s reliance on the location of the transplant or origin of the organ as a proxy for ethical concerns, rather than a case-by-case determination. The Medicaid provision’s dependence on federal CMS approval also adds an implementation constraint that may have been a practical concern.